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To date, the treatment of articular cartilage lesions remains challenging. A promising
strategy for the development of new regenerative therapies is hybrid bioprinting,
combining the principles of developmental biology, biomaterial science, and 3D
bioprinting. In this approach, scaffold-free cartilage microtissues with small diameters
are used as building blocks, combined with a photo-crosslinkable hydrogel and
subsequently bioprinted. Spheroids of human bone marrow-derived mesenchymal
stem cells (hBM-MSC) are created using a high-throughput microwell system and
chondrogenic differentiation is induced during 42 days by applying chondrogenic
culture medium and low oxygen tension (5%). Stable and homogeneous cartilage
spheroids with a mean diameter of 116 ± 2.80 µm, which is compatible with
bioprinting, were created after 14 days of culture and a glycosaminoglycans (GAG)-
and collagen II-positive extracellular matrix (ECM) was observed. Spheroids were able
to assemble at random into a macrotissue, driven by developmental biology tissue
fusion processes, and after 72 h of culture, a compact macrotissue was formed. In
a directed assembly approach, spheroids were assembled with high spatial control
using the bio-ink based extrusion bioprinting approach. Therefore, 14-day spheroids
were combined with a photo-crosslinkable methacrylamide-modified gelatin (gelMA)
as viscous printing medium to ensure shape fidelity of the printed construct. The
photo-initiators Irgacure 2959 and Li-TPO-L were evaluated by assessing their effect
on bio-ink properties and the chondrogenic phenotype. The encapsulation in gelMA
resulted in further chondrogenic maturation observed by an increased production of
GAG and a reduction of collagen I. Moreover, the use of Li-TPO-L lead to constructs
with lower stiffness which induced a decrease of collagen I and an increase in
GAG and collagen II production. After 3D bioprinting, spheroids remained viable and
the cartilage phenotype was maintained. Our findings demonstrate that hBM-MSC
spheroids are able to differentiate into cartilage microtissues and display a geometry
compatible with 3D bioprinting. Furthermore, for hybrid bioprinting of these spheroids,
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gelMA is a promising material as it exhibits favorable properties in terms of printability
and it supports the viability and chondrogenic phenotype of hBM-MSC microtissues.
Moreover, it was shown that a lower hydrogel stiffness enhances further chondrogenic
maturation after bioprinting.
Keywords: bioprinting, spheroids, chondrogenesis, differentiation, stem cell, fusion, self-assembly
INTRODUCTION
Articular cartilage, the connective tissue lining the articular
surface of bones within diarthrodial joints, ensures load support,
load transmission, and joint lubrication. It is characterized
by a limited intrinsic healing and repair capacity because of
its avascular and aneural nature. Therefore, articular cartilage
lesions are prone to progress to osteoarthritis and patients
are liable to suffer from joint instability in the long term
(Fox et al., 2009, 2012).
Nowadays, articular cartilage defects are already being treated
with cell-based regenerative therapies, such as autologous
chondrocyte implantation (ACI). This two-step surgical
procedure includes the isolation of autologous articular
chondrocytes from a non-weight bearing region, the in vitro
expansion and the reinjection into the defect site (Davies and
Kuiper, 2019). Another commonly used approach is Matrix-
assisted ACI (MACI) which is an ex vivo engineered hybrid
construct, where isolated autologous chondrocytes are seeded
onto a biomaterial, a bovine-derived type I/III collagen scaffold,
before implantation in the defect (Foldager et al., 2012; Basad
et al., 2015). However, the harvesting procedure to obtain
chondrocytes can induce donor-site morbidity and the 2D
expansion of articular chondrocytes is characterized by long
in vitro culture periods and chondrocyte dedifferentiation to a
more fibroblast-like phenotype featuring a decrease in collagen
II, aggrecan, and glycosaminoglycans (GAG) (Caron et al.,
2012; De Moor et al., 2019). This results in the generation of
repair tissue which is biochemically and hence biomechanically
inferior compared to the native cartilage (Knutsen et al., 2007).
Therefore, new biofabrication strategies are being explored in the
quest for novel regenerative therapies.
For the creation of cartilage constructs, a modular tissue
engineering concept is emerging. This approach is inspired by
developmental biology where complex tissues are comprised
of repeating functional units (Nichol and Khademhosseini,
2009). Instead of starting from single cells, smaller tissue
units such as cell sheets or cellular spheroids are used as
building blocks to create larger tissues by self-assembly and
fusion. The 3D spatial arrangement of cells into spheroids
mimics the natural environment by creating cell–cell contacts
and cell–extracellular matrix (ECM) interactions, enhancing cell
differentiation (Mironov et al., 2009; Schon et al., 2017). Injection
of spheroids can be used to treat cartilage defects instead of
injecting a single cell suspension, whose dedifferentiation leads
to inferior fibrous tissue. Spheroid maturation already starts
in vitro, establishing a tissue specific ECM provoked by their high
cellularity and cell density (Huang et al., 2016; De Moor et al.,
2019). An example used in clinical trials are chondrospheres,
500–800 µm spheroids generated from autologous chondrocytes.
The chondrospheres naturally adhere to the cartilage defect after
injection and assemble and fuse at random (Anderer and Libera,
2002; Becher et al., 2017).
As an alternative to injecting or assembling spheroids at
random, 3D printing technologies can be used to assemble the
cellular building blocks in a directed manner with high spatial
control in a complex predesigned configuration. In bio-ink based
extrusion bioprinting, biomaterials can be used as viscous carriers
for the deposition of cells or spheroids, to restrain them and
to ensure shape fidelity of the printed construct (Moldovan
et al., 2018). Moreover, hydrogels are widely used in cell-based
cartilage regeneration as a pro-chondrogenic environment as
they can mimic the biological and physical properties of the
native ECM (Vega et al., 2017). Next to alginate or agarose
hydrogels, commonly used for chondrocyte redifferentiation,
gelatin-based hydrogels are an optimal candidate to use as an
ink because of their low-cost, high water content, cell-interactive
properties and resemblance with the natural ECM as a derivative
from collagen (Cigan et al., 2016; Ewa-Choy et al., 2017; Pahoff
et al., 2019). Methacrylamide-modified gelatin (gelMA), also
frequently referred to as gelatin methacryloyl in the literature, is a
modified photo-crosslinkable form of the natural polymer gelatin
combining stability (after crosslinking) at 37◦C and allowing
interaction, adhesion and migration of cells by the presence of the
integrin binding Arg-Gly-Asp (RGD) sequence. GelMA solutions
are interesting for extrusion bioprinting as thermally initiated
(reversible) gelation can create a viscous gel-like solution, ideal
for extrusion, by applying a printing temperature below 30◦C
(Van Den Bulcke et al., 2000; Pepelanova et al., 2018). GelMA
can be chemically crosslinked by a UV-induced chain growth
polymerization mechanism in the presence of a photo-initiator
(PI), which transfers the electromagnetic energy of the UV-light
into chemical energy by generating radicals and initiating the
polymerization (Tytgat et al., 2018). Hydrogel properties can be
tailored by varying polymer concentration, crosslinking times
or by using different PIs (Rouillard et al., 2011; Billiet et al.,
2014; Loessner et al., 2016; Pahoff et al., 2019). Irgacure 2959
is a commonly used PI but its water solubility is very limited,
therefore there is a shift to PIs with higher water solubility
such as Li-TPO-L (Markovic et al., 2015; Tytgat et al., 2018).
It has been demonstrated that gelMA supports cartilage-like
matrix production when a suspension of single chondrocytes or
mesenchymal stem cells (MSC) were embedded (Hu et al., 2009;
Schuurman et al., 2013; Mouser et al., 2018; Pahoff et al., 2019).
Recently, there has been an increased interest in the use of adult
MSC in cartilage regeneration because of their multipotency
and ability to differentiate into chondrogenic lineages after
expansion in vitro and intra-articular injections of MSC have
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been performed to reduce osteoarthritic pain or induce cartilage
repair (Jo et al., 2014; Shin et al., 2018). The use of MSC
would also eliminate the need for harvesting surgery within
the damaged knee-joint or donor site. Spheroid formation of
stem cells resembles the aggregation and condensation processes
of mesenchymal progenitor cells during embryonic cartilage
development (Ghosh et al., 2009). Next to culturing MSC in
3D, differentiation into the chondrogenic lineage can be induced
by applying a chondrogenic culture medium containing growth
factors such as transforming growth factor-β (TGF-β) and/or
bone morphogenetic protein (BMP) (Ude et al., 2017). Further
mimicking of the natural environment can be done by culturing
in a low oxygen environment as hypoxia results in an increase of
cartilage ECM molecules such as collagen II and aggrecan (Tan
et al., 2011; Berneel et al., 2016).
For hyaline cartilage tissue engineering, mainly large diameter
spheroids (>500 µm) are created using articular chondrocytes
(Anderer and Libera, 2002; Armoiry et al., 2018). Though for
bioprinting, small diameter spheroids with uniform shapes and
sizes are necessary for compatibility with the print needle.
In our previous study, we described the biofabrication of
printable high quality cartilage microtissues starting from porcine
chondrocytes (De Moor et al., 2019). However, to enhance clinical
translation, we describe the high-throughput creation of small
diameter human cartilage spheroids (<200 µm) by chondrogenic
differentiation of human bone marrow-derived mesenchymal
stem cells (hBM-MSC), applying chondrogenic culture medium
and low oxygen tension (5%). To generate the spheroids, a
low-cost non-adhesive microwell system is used (Figure 1).
Moreover, the fusion capacity of the cartilage microtissues in
suspension and within a hydrogel is investigated. We investigated
if gelMA is a suitable conductive microenvironment for spheroid
differentiation by extensive screening of ECM by histology. In the
final phase of the study, the processing potential of the bio-ink,
consisting of cartilage microtissues and gelMA, and the impact
of the extrusion-based bioprinting on viability and cartilage
phenotype were assessed (Figure 1).
MATERIALS AND METHODS
Cell Culture
Human Bone Marrow-derived Mesenchymal Stem Cells were
purchased from PromoCell GmbH (C-12974, male donor age
65). Cells were cultured in MSC Growth Medium 2 (C-28009,
PromoCell GmbH) supplemented with 50 U/ml penicillin and
50 µg/ml streptomycin (Life technologies) and maintained at
37◦C in a humidified 5% CO2-containing atmosphere. Cells were
subcultured at 80% confluency. Passage 3–5 cells were used to
generate spheroids in this study. Passage 3 cells were applied in
the fusion experiments and passage 4 and 5 cells were used in all
other experiments.
Fabrication of Non-adhesive Microwells
Spheroids are generated using a high-throughput non-
adhesive agarose microwell system, as previously described
(Gevaert et al., 2014; Berneel et al., 2016; Roosens et al., 2017;
De Moor et al., 2018, 2019). In brief, polydimethylsiloxane
(PDMS) molds (NaMiFab, Ghent University) with a diameter of
18 mm and a height of 3 mm, containing 1585 micropores of
400 µm diameter each, are used as a negative replica to create
microwells (Figure 1A). A 4.5 w/v% Ultrapure agarose solution
(Life technologies) dissolved in sterile phosphate buffered saline
(PBS) was heated and poured on top of the PDMS mold. Once
the agarose solidified, the agarose microwell was separated from
the mold and placed in a 12-well plate.
Generation of 3D Microtissues
Cells were harvested and 500 µl of cell suspension, containing
5.0 × 105 cells, was seeded onto the microwell, resulting in
approximately 315 cells per pore. One hour after seeding,
cells lowered into the pores by gravitational force. To induce
chondrogenesis, spheroids were cultured in a serum-free
chondrogenic culture medium comprised of Dulbecco’s
Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F12,
Life Technologies), 1 mM sodium pyruvate (Life technologies),
0.5% (v/v) ITS (Sigma-Aldrich), 10 U/mL penicillin, 10 µg/mL
streptomycin, 100 µM dexamethasone (Sigma-Aldrich),
200 µM L-ascorbic acid-2-phosphate (Sigma-Aldrich), and
10 ng/mL TGF-β1 (Peprotech), in a low oxygen tension
(5% O2) incubator at 37◦C. Spheroids were cultured up to
42 days and culture medium was refreshed after the first
24 h of culture and afterward every 2 days. Aggregation
of the cells was evaluated microscopically (Olympus IX81)
and spheroids were harvested after 7, 14, 21, 28, 35, and
42 days of culture. Spheroid morphology was analyzed with
the Xcellence image software (Olympus). Spheroid diameter,
area (A) and perimeter (p) were measured and circularity
was calculated using the formula f circularity = (4piA)/p2. For
the evaluation of diameter and circularity, 18 spheroids
(n = 3), were assessed.
At Random Assembly of Spheroids:
Fusion Assays
As spheroids were used as building blocks to create larger tissues,
their capacity to fuse at random was tested by using two methods.
Fusion of Doublets
Spheroid doublets were formed based on the method of
Susienka et al. (2016). Medium was carefully removed
from two microwells containing immature 7-days-cultured
spheroids. The recipient chip (microwell 2) was then
transferred into a new 12-well plate. The walls of the donor
chip (microwell 1) were removed using a punching device
and the remaining central portion was gently inverted onto
the recipient chip. After centrifugation, the donor chip was
removed leaving the recipient chip with numerous spheroid
doublets and 2 ml of chondrogenic medium was gradually
added (Figure 2A). Images of 14 doublets were analyzed
after 0, 2, 6, 8, 10, 24, 48, 72, 96, and 168 h of culture.
Intersphere angle, doublet length, doublet width, and contact
length (indicated in Figure 2B) of the fused doublets were
measured in ImageJ.
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FIGURE 1 | Experimental study design. (A) Printable micro building blocks (spheroids) for the creation of a larger construct are generated in high-throughput using
non-adhesive microwells. Agarose microwells are created by using a PDMS mold as a negative replica. After seeding, cells lower into the pores of the microwell and
self-assemble into 3D cellular spheroids. (B) Spheroids are combined with a hydrogel precursor solution, a methacrylamide-modified gelatin for (C) 3D bio-ink based
bioprinting of a construct using extrusion.
FIGURE 2 | Schematic representation of doublet fusion assay. (A) Spheroids are pairwise placed by inverting a donor microwell (microwell 1) on top of a recipient
microwell (microwell 2) and after centrifugation, the donor microwell was removed, leaving spheroid doublets in microwell 2. (B) Morphological parameters measured
during fusion.
Fusion of Multiple Spheroids
To assess the capacity of multiple spheroids to fuse into a
macrotissue, 7-day-old spheroids were fused in an agarose coated
well. A 2 w/v% agarose solution was prepared and a coating
was applied in a 96-well plate (Greiner) by pipetting 300 µl
per well and subsequently removing 270 µl. After 7 days
of culture, spheroids of one microwell were harvested and
resuspended in 160 µl chondrogenic medium. Per agarose coated
well, 20 µl of the spheroid suspension was seeded, resulting in
200 spheroids per well. After seeding, 200 µl of chondrogenic
medium was carefully added. Follow-up of the at random fusion
was carried out at several time points: 0, 2, 6, 8, 24, 48,
72, 96, and 168 h.
Biopolymer and Photo-Initiator
Preparation
Methacrylamide-modified gelatin was provided by the Polymer
Chemistry and Biomaterials Research group (Ghent University)
and was prepared by functionalization of the primary amines of
the (hydroxy)lysine and ornithine side groups present in bovine
type B gelatin (Rousselot) with methacrylic anhydride (Sigma-
Aldrich) (Van Den Bulcke et al., 2000; Van Hoorick et al., 2017;
Tytgat et al., 2019). Briefly, 100 g gelatin (0.000385 mol amines/g)
was dissolved in 1 L phosphate buffer (pH 7.8) at 40◦C. One
equivalent of methacrylic anhydride (0.0385 mol, 5.7 ml) was
added dropwise while stirring for 1 h. The mixture was dialyzed
against distilled water using dialysis membranes for 24 h. The
degree of substitution of purified gelatin methacrylamide was
78%, as determined by 1H-NMR spectroscopy (Bruker AVANCE
II 500 MHz). Freeze-dried gelMA was sterilized by a cold
ethylene oxide treatment (AZ Sint-Jan, Bruges, Belgium) before
use. 10 w/v% solutions of gelMA, dissolved in sterile autoclaved
PBS while stirring at 37◦C, were used. To initiate photo-
crosslinking, Irgacure 2959 (1-[4-(2-hydroxyethoxy)-phenyl]-2-
hydroxy-2-methyl-1-propane-1-one) (BASF) or lithium phenyl-
2,4,6-trimethylbenzoylphosphinate (Li-TPO-L or LAP) (kindly
provided by the Polymer Chemistry and Biomaterials Research
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group, Ghent University, synthesized as previously reported by
Markovic et al. (2015), dissolved in PBS, were used as PI. 2 mol%,
relative to the amount of methacrylamides present was added to
the gelMA solution. Before adding, stock solutions of 0.8 w/v%
of Irgacure or Li-TPO-L were sterilized using a 0.22 µm pore
filter (Millipore).
Hydrogel Characterization
To evaluate the effect of different PIs on the hydrogel properties,
gel fraction, swelling ratio and Young’s moduli of cell-free
gelMA/Irgacure 2959 or gelMA/Li-TPO-L hydrogel samples were
determined. Hydrogel disks (diameter = 10 mm, height = 2 mm)
were prepared by pipetting 800 µl of a 10 w/v% gelMA solution,
containing 2 mol% Irgacure 2959 or Li-TPO-L, relative to the
amount of methacrylamides present in gelMA, in a 6-well plate.
After 10 min of physical gelation at room temperature (RT), gels
with Irgacure 2959 as PI were photo-crosslinked for 20 min with a
UV-A broad spectrum light (365 nm, 4 mW/cm2, UVP Inc.), gels
with Li-TPO-L were crosslinked using a UV-LED incorporated in
the RegenHu bioprinter for 60 s (365 nm, 200 mW/cm2). Disks
of 10 mm diameter were punched out using a punching device.
Gel Fraction and Swelling Ratio
Gel fraction and swelling ratio of the gels was determined.
Samples were dried in a desiccator for 2 weeks and weighed
(Wd0), followed by swelling overnight in PBS at 37◦C and
weighed again (Ws). Subsequently, the samples were dried and
weighed again (Wd1). The gel fraction and swelling ratio were
defined as:
Gel fraction (%) = Wd1
Wd0
× 100
Swelling ratio (%) = Ws −Wd0
Wd0
× 100
Compression Test
After crosslinking, hydrogel disks were compressed using
a universal testing machine (LRXplus, Lloyd Instruments)
equipped with a 100 N load cell, at a rate of 5 mm/min. Hydrogel
disks were compressed at RT over a distance of 1 mm and
Young’s moduli (kPa) were calculated. All measurements were
prepared in fivefold.
Encapsulation of Spheroids in gelMA
Spheroids were combined with gelMA as a viscous printing
medium for bio-ink based bioprinting by extrusion (Figure 1B).
To examine the effect of hydrogel properties and PI type
on spheroid morphology, viability and phenotype, hydrogel
encapsulation experiments without printing were performed.
Spheroids were encapsulated in 10 w/v% gelMA containing either
Irgacure 2959 or Li-TPO-L as PI. Spheroids were collected from
the microwells after 14 days of culture by vigorously resuspending
the culture medium. After centrifugation, supernatant was
removed and the gelMA/PI solution was added to the spheroid
pellet. Hydrogel disks of 250 µl were prepared by pipetting
spheroid/gelMA/PI solution in a 48-well plate. Per 250 µl
gel, spheroids of 3 microwells were encapsulated resulting in
±4755 spheroids/gel. After physical crosslinking for 10 min at
RT, gelMA/Irgacure 2959 gels and gelMA/Li-TPO-L gels were
photo-crosslinked as described above (see section “Hydrogel
Characterization”). Gels were transferred to a 12-well plate and
chondrogenic medium was added. Medium was exchanged after
24 h and then every other 2 days, encapsulated spheroids were
cultured for 14 days.
Directed Assembly of Spheroids:
3D Extrusion-Based Bioprinting
The processing potential of the bio-ink, gelMA/Li-TPO-L
containing 14-day-old spheroids, was evaluated using extrusion-
based 3D bioprinting, to create controlled formation of a larger
construct (Figure 1C). Spheroids from 8 microwells (±12680
spheroids) were collected by vigorously resuspending the culture
medium. After centrifugation, supernatant was removed and
1.0 ml of a 10 w/v% gelMA/Li-TPO-L solution was added to
the pellet of spheroids. As a control, constructs containing single
cells instead of spheroids were also printed. 4 × 106 hBM-
MSC were collected and 1.0 ml of a 10 w/v% gelMA/Li-TPO-L
solution was added to the cell pellet. After homogenization,
the bio-ink solution was transferred into a cartridge and placed
into the cartridge heater at 25◦C for 30 min. Scaffolds were
produced using the 3D Discovery Instrument (RegenHU),
operated by human machine interface (HMI) and BioCAD
software, equipped with a pneumatic dispensing printhead.
A polyethylene conical needle with an inner diameter of 0.41 mm
was used to print the scaffold by extrusion at feed rate of 5 mm/s.
The printed scaffolds (1.3×1.3 cm) contained four layers of bio-
ink (two horizontal, two vertical), printed with a theoretical strut
thickness of 0.328 mm (80% of the needle’s inner diameter).
A pressure of approximately 0.035 MPa was applied and manually
adjusted during the printing process of the constructs. After
printing, scaffolds were physically crosslinked at RT for 10 min
and photopolymerization of the scaffolds was induced by the UV-
LED incorporated in the RegenHu bioprinter for 60 s (365 nm,
200 mW/cm2). All printing parameters are described in Table 1.
Scanning Electron Microscopy
Bioprinted scaffolds containing cartilage microtissues were
washed two times with PBS and fixed in 2% glutaraldehyde in
TABLE 1 | Printing parameters.
Parameter Value
Cartridge temperature 25◦C
Extrusion pressure 0.035 MPa
Ambient temperature 21◦C
Feed rate 5 mm/s
Needle diameter 0.41 mm
Theoretical strut thickness 0.328 mm
Layers 4
Spheroid concentration ±12680/ml
Physical crosslinking 10 min at 4◦C
UV irradiation time 60 s
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0.1 M cacodylatebuffer (pH 7.2) for 3 h at RT. Next, scaffolds
were washed three times in 0.1 M cacodylatebuffer, dehydrated
in graded alcohol concentrations (30 min of 50%, 70%, 85%,
and 95%) and completely dried by using hexamethyldisilazane
(Sigma-Aldrich). Once dried, scaffolds were first coated with a
thin layer of gold making use of a sputter coater (JFC-1300
auto fine coater, JEOL) to avoid charge accumulation. Scanning
electron microscopy (SEM) (JSM-6010 PLUS/LV; JEOL) images
were used to examine the morphology of the scaffolds and
spheroids, and were obtained with an accelerating voltage of 7 kV
at a working distance of 11 mm.
Live/Dead Viability Assay
To determine cell viability, spheroids, hydrogel samples or
bioprinted scaffolds were harvested, two times washed with
PBS and incubated with calcein-AM (2 µg/ml, Anaspec)
and propidium iodide (2 µg/ml, Sigma). After 10 min
of incubation, spheroid viability was evaluated using an
inverted fluorescence microscope (Olympus IX81) equipped with
Xcellence software (Olympus).
(Immuno)Histochemical Evaluation of
Proliferation and Extracellular Matrix
Components
Spheroids of 2 microwells were collected and pooled for
histological analysis. Hydrogels and bioprinted scaffolds were
rinsed with PBS 2 times prior to fixation. All samples were
fixed overnight at 4◦C with 4% paraformaldehyde, dehydrated
in graded alcohol concentrations and embedded in paraffin.
Paraffin sections of 5 µm thickness were cut, deparaffinized,
and rehydrated. Sections were stained with hematoxylin/eosin
(HE) (VWR/Thermo Fisher), Alcian Blue, and Picrosirius
Red (PSR), in accordance to standard protocols, to analyze
overall morphology and ECM components as GAG and
collagen, respectively.
The distribution of collagen type II and collagen type I
was visualized by immunohistochemistry (IHC). Heat induced
antigen retrieval was performed using citrate buffer (pH 6,0,
2 × 5 min) at 90◦C, followed by 10 min incubation with 3%
H2O2 to block endogenous peroxidase activity. After 30 min
blocking with a blocking solution (1% w/v Bovine Serum
Albumin, 5% v/v normal rabbit serum, 0.2% v/v Tween 20),
sections were incubated with monoclonal mouse anti-collagen
II antibody for 2 h at RT (1:50, sc-518017, SantaCruz) or a
monoclonal mouse anti-collagen I antibody (1:50, sc-293182,
SantaCruz) at 4◦C overnight. This was followed by a biotinylated
rabbit anti-mouse antibody (1:200, E0413, Dako) as secondary
antibody for 30 min. After washing, sections were treated
with streptavidin-horseradish peroxidase for 30 min (1:200,
Dako) after which 3,3-diaminobenzidine tetrahydrochloride
(DAB, Sigma) served as a chromogen to visualize the coupled
secondary antibody.
To assess proliferation, sections were stained with a mouse
monoclonal antibody against the proliferation marker Ki67 (1:50,
M7240, Dako). Staining procedure was similar as described
above. The number of Ki67+ was manually counted and are
reported in Supplementary Figure S1. All IHC stained sections
were counterstained with Mayer’s hematoxylin and examined
using an Olympus BX51 microscope. Sections were thoroughly
screened and only images representative for the majority of the
spheroids, hydrogels and scaffolds were selected.
Histomorphometric evaluation was performed to quantify
the presence of the ECM components (GAG, collagen type
I and type II). In brief, histological images (20× objective,
Olympus BX51) were analyzed using the color deconvolution
(“Alcian Blue and H” and “H DAB” vector) method in Image
J. Automatic thresholding (RenyiEntropy method) was applied
for the selection of GAG, collagen type I and collagen type
II positive regions within spheroids. Positive stained area is
shown as a ratio to the region of interest (ROI), i.e., total
area of all spheroids on the slide. All measurements were
performed in sixfold.
Statistical Analysis
Data were analyzed using SPSS version 26.0 (SPSS GmbH
Software) and are represented as the mean ± 95% confidence
interval (CI). To test for normality of the variables, the Shapiro–
Wilk test was used. The homogeneity of the variances was
assessed with the Levene’s test. For data with a non-normal
distribution, a Kruskal–Wallis test was performed. For the
analysis of data with a normal distribution and homogeneous
variances, a one-way ANOVA and Tukey’s post hoc test were
performed. For data with a normal distribution with non-
homogeneous variances, a Welch’s ANOVA test followed by
a Games-Howell post hoc test were executed. For hydrogel
properties, where two groups were compared and groups
were normally distributed, an independent samples t-test was
performed. P values < 0.05 were considered significant.
RESULTS
Cartilage Microtissues
High-Throughput Formation of Cartilage
Microtissues
Spheroids were created using a non-adhesive agarose microwell
system (Figure 1A). After seeding of the hBM-MSC suspension
on the microwells, cells lowered into the bottom of the pores by
gravitational force within 1–2 h and cells were distributed over
the entire surface of the pore. Cells self-assembled spontaneously
into slightly irregular shaped spheroids after 1 day of culture
(Figure 3A). With increasing culture time, spheroids became
more rounded and compact which is accompanied by a
significant reduction in diameter from 131.68 ± 2.80 µm on day
7 to 116,28 ± 6.89 µm on day 21. Diameter slightly increased
to a mean diameter of 122.09 ± 6.38 µm after 42 days of
culture (Figure 3C). The circularity of the spheroids remained
stable (±88%) (Figure 3D). Live/dead staining with calcein-
AM/PI (Figure 3B) revealed high cell viability, cell dead is mostly
observed at the periphery of the spheroids and in detached
single cells. Few dead cells can be detected in the core of the
spheroids, especially after 42 days of culture (indicated by white
arrows, Figure 3B).
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FIGURE 3 | Formation of cartilage microtissues: morphology and viability. (A) hBM-MSC lowered spontaneously into the pores of the microwell. After 1 day of
culture irregular shaped spheroids were formed. (B) Light microscopy and live/dead staining of spheroids over time in culture, white arrows indicate dead cells.
(C) Evaluation of spheroid diameter and (D) circularity (n = 3, Welch’s ANOVA test followed by a post hoc Games-Howell, significant differences were marked as
*p < 0.05). All data are presented as mean ± 95% CI. All scale bars represent 200 µm.
Proliferation and Maturation of Cartilage
Microtissues
Histological analysis was performed to screen overall
morphology (HE), proliferation (Ki67), and cartilage ECM
(Figure 4). HE staining shows the presence of nuclei throughout
the spheroid. Nuclei appeared more flattened at the periphery of
the spheroid (indicated by black arrows, Figure 4A). Spheroids
displayed a cartilage-like morphology with lacunae with
increasing culture time (indicated by white arrows, Figure 4A).
Proliferation within the spheroids was evaluated by
performing an IHC staining against the proliferation marker
Ki67. Staining showed that Ki67 positive cells were mostly
located in the outer rim of the spheroids (Figure 4A). The
highest number of Ki67+ cells was reported after 7 days of
culture (2.14 ± 0.85 cells/spheroid) (Supplementary Figure S1).
On day 28, spheroids presented a significant higher number
of Ki67 positive cells (1.31 ± 0.55 cells/spheroid) as compared
to day 21 (0.31 ± 0.30 cells/spheroid), which correlates with
the increase in diameter (Figure 3C). The number of Ki67
positive cells reduced after 35 and 42 days in culture (0.17± 0.26
and 0.08 ± 0.20 cells/spheroid, respectively (Figure 4A and
Supplementary Figure S1).
To induce chondrogenic differentiation of hBM-MSC
spheroids to mature cartilage microtissues, serum-free
chondrogenic culture medium and low oxygen tension (5%)
were applied. As the goal of our study is to develop articular
cartilage-like microtissues, composition and distribution of
cartilage specific ECM components was extensively screened.
GAG were visualized by Alcian Blue staining. From day 7,
slightly positive staining for GAG was detected (12.16 ± 2.57%),
especially in the spheroid core. With increasing culture time,
positive stained area and staining intensity both increased
(46.13 ± 4.36% on day 42), resulting in the presence of GAG
covering the entire spheroid area (Figures 4A,B). Picrosirius Red
staining showed slightly positive collagen fibers in the 7-day-old
spheroids and from 14 days in culture, mature fibrillar collagen
was demonstrated (black arrows, Figure 4A). Starting from day
21, a clear presence of fibers especially located at the periphery
of the spheroid was reported (black arrows, Figure 4A). This
corresponds to the IHC localization of collagen type I, where
fibers showed to be present exclusively in the outer rim of the
spheroids, covering 2.49 ± 2.36% of the spheroid area after
7 days of culture and increased to 29.64 ± 4.90% after 42 days of
culture (Figures 4A,B). This is in contrast to the distribution of
collagen type II, which is more dispersed throughout the entire
spheroid. Collagen type II manifested starting from 14 days of
culture, mainly situated at the periphery covering 28.56 ± 3.52%
of spheroid area, and the positively stained area increased with
increasing culture time, stretching toward the center covering
61.83 ± 4.40% of the spheroid area on day 42 (Figures 4A,B).
Some spheroids are devoid of collagen type II in the center but
Alcian Blue staining shows the presence of GAG in the core of
the spheroid (Figure 4A).
Cartilage Microtissue Fusion Into
a Macrotissue
To investigate the potential and time frame of immature
7-day-old cartilage microtissues to fuse, spheroids were placed
in close proximity to each other by performing a doublet
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FIGURE 4 | (Immuno)histological evaluation of cartilage microtissues: proliferation and extracellular matrix. (A) HE staining was performed to assess overall
morphology, black arrows indicate flattened nuclei of cells at the periphery and white arrows indicate lacunae. IHC staining for Ki67 indicated proliferating cells,
Alcian Blue staining showed the presence of glycosaminoglycans (GAG). Collagen was visualized by Picrosirius Red (PSR) staining, black arrows indicate mature
fibrillar collagens. IHC stainings for collagen type I and type II were performed, black arrows indicate collagen type I fibers. Scale bar 20 µm. (B) Quantification of
GAG, collagen I and collagen II positive stained areas. All data are presented as mean ± 95% CI. Significant differences (p < 0.05) were marked a compared to day
7, b to day 14, c to day 21, d to day 28, e to day 35, and f to day 42 (n = 6, One-way ANOVA followed by a Tukey’s post hoc test).
formation assay (Figure 2; Susienka et al., 2016). For the creation
of spheroid doublets, the donor microwell was cropped and
inversely stacked on the recipient microwell. After centrifugation
spheroids of the donor microwell lowered into the wells of the
recipient microwell, resulting in pairwise placement of spheroids,
creating doublets (Figure 5A). Microwells comprising triplets
and quadruplets were excluded for evaluation. During fusion,
doublets rotated both clock- and counterclockwise in the pores
of the microwell. To analyze the time span of fusion of a mature
cartilage microtissue, morphological changes during the first
hours of the fusion process were imaged. Doublet length, doublet
width, intersphere angle and contact length between spheroids
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FIGURE 5 | Fusion of cartilage microtissue doublets. (A) Cartilage microtissues at maturation stage of 7 days were harvested and doublets were formed. Spheroid
fusion was tracked for 168 h by light microscopy. Scale bar 50 µm. (B) Morphological parameters such as doublet length (µm), doublet width (µm), contact length
(µm), and intersphere angle (◦) were measured using Image J software. (n = 12, all data are presented as mean ± 95% CI). (C) Morphological and
(immuno)histochemical evaluation of fused doublets after 168 h of culture. HE staining was performed to assess overall morphology, Alcian Blue staining showed the
presence of glycosaminoglycans (GAG). Collagen was visualized by Picrosirius Red (PSR) staining and IHC stainings for collagen type I and type II were performed.
Scale bar 20 µm.
were measured. Initial contact between spheroids occurs within
the first hour (Figure 5A). As fusion progressed, doublet lengths
shortened in function of time starting from 236.53 ± 10.24 µm
to 158.91 ± 9.41 µm after 168 h. Intersphere angle and contact
length increased in function of time at a similar rate. After
72 h of fusion, the intersphere angle reached a plateau (±179◦)
and did not change anymore in function of prolonged culture
time. Contact length approached 140 µm which matches the
width of the spheroids, indicating complete spheroid fusion.
However, contact length and doublet width showed some minor
deviations indicating continuous dynamic processes in the fused
spheroids. The fused spheroid after 96 h indeed shows a more
rounded morphology compared to the oval spheroid after 72 h
(Figures 5A,B). Histological evaluation of the fused doublet after
168 h is shown in Figure 5C. Although HE staining shows
a perfectly fused doublet, ECM stainings (PSR, Alcian Blue,
collagen I, and II) clearly show the margins of the individual
cartilage microtissues. Especially collagen type I (demonstrated
by PSR and IHC) is situated at the periphery of the individual
microtissues and the fused doublet (Figure 5C). The newly
synthesized matrix surrounding the original individual spheroids
is mainly composed of collagen II (Figure 5C).
To confirm if a large number of spheroids was able to fuse into
a macrotissue, ±200 7-day-old spheroids were seeded in agarose
coated 96-wells (Figure 6). Spheroids made contact within 2 h
after seeding. After 24 h, margins between spheroids faded
and no individual spheroids could be distinguished. Further
compaction occurred and after 96 h, a circular construct of
±527 µm diameter was formed (Figure 6A). After 168 h of
fusion, histology showed the presence of GAG throughout the
entire fused tissue, collagen I and especially collagen II were
present at the periphery of the fused tissue and at the periphery
of the original individual spheroids, which still can be perceived
with histology (Figure 6B).
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FIGURE 6 | Formation of a macrotissue by fusion of multiple cartilage microtissues. (A) Cartilage microtissues at maturation stage of 7 days were harvested
and ± 200 spheroids were seeded per agarose coated 96-well. Spheroid fusion was tracked for 168 h. Scale bar 500 µm. (B) Morphological and
(immuno)histochemical evaluation of the fused microtissues after 168 h of culture. HE staining was performed to assess overall morphology, Alcian Blue staining
showed the presence of glycosaminoglycans (GAG). Collagen was visualized by Picrosirius Red (PSR) staining and IHC stainings for collagen type I and type II were
performed. Scale bar 20 µm.
Encapsulation of Cartilage Microtissues
in gelMA
Because spheroids started to developed a cartilage ECM after
14 days of culture, as demonstrated by GAG (24.06 ± 5.84%)
and collagen type II content (28.56 ± 3.52%) (Figures 4A,B),
spheroids at this maturation stage were selected to encapsulate
in gelMA. To assess the impact of the biopolymer and PI
on spheroid morphology, viability, phenotype, fusion and
outgrowth, spheroids were encapsulated in hydrogel disks of
10 w/v% gelMA. Polymerization by UV-light was performed with
2 mol% Irgacure 2959 or Li-TPO-L and their effect on hydrogel
properties was assessed as well.
Morphology, Viability and Fusion of Encapsulated
Cartilage Microtissues
Spheroids encapsulated in gelMA displayed a round morphology
(Figure 7). In the gelMA/Irgacure2959 hydrogels, cellular
outgrowth was observed after 7 days. In contrast, when
Li-TPO-L was used as a PI, more cellular outgrowth was
observed after 7 and 14 days post encapsulation. After 14 days,
cellular sprouts were spread within the entire hydrogel disk.
Live/dead staining showed that spheroids and their cellular
outgrowths remained viable in all hydrogels, regardless the
PI used for photopolymerization (Figure 7A). Encapsulated
spheroids located in near vicinity of each other still have
the capacity to fuse, as indicated by the black and white
arrows in Figure 7B. Nevertheless, spheroid fusion post
encapsulation is strongly dependent on the position of the
spheroids within the hydrogel and progresses slower. Only
incomplete fusion is reached during the 14-day time frame of
the encapsulation experiment, reaching an intersphere angle of
±127◦. This is in contrast with the non-encapsulated spheroid
doublets where complete fusion (intersphere angle of ±180◦) is
obtained after 72 h.
Physico-Chemical Properties of GelMA
The mechanical and physico-chemical properties including
Young’s modulus, gel fraction and swelling behavior were
evaluated for cell-free gelMA hydrogel disks, crosslinked in the
presence of Irgacure 2959 or Li-TPO-L (Figure 7C). Irgacure
2959 as PI resulted in samples with significantly higher Young’s
moduli (9.84 ± 1.22 kPa) compared to Li-TPO-L samples
(6.69± 1.25 kPa).
The results of the swelling test indicate that all conditions
were able to absorb large quantities of water, which mimics
the content of native cartilage tissues as cartilage is mainly
composed of water (80%). Li-TPO-L crosslinked hydrogels
showed significantly higher swelling (565.1± 13.87%) compared
to Irgacure 2959 crosslinked hydrogels (382.59 ± 27.78%).
Irgacure 2959 crosslinked hydrogels had a lower gel fraction
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FIGURE 7 | Influence of gelMA properties on spheroid morphology, viability, and fusion. (A) Cartilage microtissues at maturation stage of 14 days were harvested
and were encapsulated in gelMA using either Irgacure 2959 or Li-TPO-L as a photo-initiator. Morphology and viability of encapsulated spheroids 7 and 14 days post
encapsulation. Scale bars 200 µm. (B) Cellular outgrowth and fusion of 14-day-matured cartilage microtissues within gelMA after 14 days of culture in the hydrogel,
fused spheroids are indicated by the black arrows. (C) Young’s modulus, gel fraction and swelling ratio were assessed on cell-free gelMA hydrogel samples (n = 5,
independent samples t-test). All data are presented as mean ± 95% CI and significant differences were marked as *p < 0.05.
(68.84% ± 0.81) compared to Li-TPO-L crosslinked hydrogels
(88.61%± 1.48).
Influence of GelMA on Proliferation and Cartilage
Phenotype
Hematoxylin/eosin staining showed that the hydrogel
encapsulation process did not change the morphology of
the spheroids. In contrast, immunohistochemical staining for
Ki67 demonstrates that encapsulated cells rarely proliferated,
only few positive cells were found (0.29 ± 0.49 and
0.43 ± 0.53 cells/spheroid after 7 and 14 days of encapsulation,
respectively) (Figure 8).
Histological analysis was performed to assess the effect
of gelMA encapsulation on the cartilaginous phenotype of
the spheroid. Alcian Blue staining showed the presence of
GAG which increased with extending culture time, though not
significantly, from 47.33 ± 3.46% 7 days post encapsulation
to 54.52 ± 5.47 14 days post encapsulation (Figures 8, 11B).
Moreover, combination with gelMA seems to have a positive
effect on GAG production, indicated by a significantly higher
positively stained area by Alcian Blue staining in the encapsulated
spheroids (Figure 8) as compared to the non-encapsulated
spheroids (37.59 ± 4.00% and 41.19 ± 3.69% on day 21
and 28, respectively) (Figures 4, 11B). For the evaluation of
collagen content, PSR, collagen type I, and type II stainings were
performed. Once encapsulated in gelMA, only slightly positive
staining for collagen type I was observed. This reduction in
collagen type I content in encapsulated spheroids (1.81 ± 1.01%
7 days post encapsulation and 4.68 ± 3.78% 14 days post
encapsulation) was significant as compared to non-encapsulated
controls (12.57 ± 2.97% and 28.04 ± 3.05% on day 21 and
28, respectively) (Figure 11B). Spheroids in gelMA/Li-TPO-
L hydrogels showed a reduced presence of collagen type I
as compared to gelMA/Irgacure 2959 hydrogels. Moreover,
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FIGURE 8 | Evaluation of cartilaginous phenotype 7 and 14 days post encapsulation in gelMA. Comparison of Irgacure 2959 or Li-TPO-L as a photo-initiator. HE
staining was performed to assess overall morphology, IHC staining for Ki67 indicated proliferating cells, Alcian Blue staining showed the presence of
glycosaminoglycans (GAG). Collagen was visualized by Picrosirius Red (PSR) staining and IHC stainings for collagen type I and type II were performed. Scale bar
20 µm.
spheroids encapsulated in gelMA/Li-TPO-L hydrogels had a
higher and more dispersed collagen type II content (Figure 8).
Collagen type II content was not affected by encapsulation
(Figure 11B). Therefore, this condition was selected for
further experiments.
Extrusion Bio-Ink Based 3D Bioprinting
of Cartilage Microtissues
The processing potential of the bio-ink, consisting of gelMA/Li-
TPO-L containing cartilage microtissues at maturation
stage of 14 days was evaluated using extrusion-based 3D
bioprinting (Figure 9). Processing parameters such as ambient
temperature, cartridge temperature, needle type, and diameter,
were optimized (Table 1).
Scaffolds (1.3× 1.3 cm) composed of four layers in a 0/90◦ lay-
down pattern were printed according to a computer-aided design
(CAD), using an applied pressure of approximately 0.035 MPa
[Figure 9A(a)]. Scaffolds displayed highly controlled macropore
morphology, with pore sizes around 800 µm and struts with a
mean thickness of 480.01 ± 20.90 µm (measured after 30 min
immersion in culture medium post printing). Spheroids were
dispersed throughout the entire scaffold [Figure 9A(b–f)]. SEM
analysis was performed after 4 days of culture to investigate
scaffold and spheroid morphology (Figure 9B). The dehydration
process for SEM analysis caused shrinkage of the scaffold
samples. SEM of the gelMA showed an organized networked
structure. Spheroids show cellular outgrowth [white arrows,
Figure 9B(c,e)] and when placed adjacent to each other, cellular
sprouts made contact, initiating spheroid fusion [black arrow,
Figure 9B(c)]. Brightfield images after 4 and 14 days of culture
(Figure 9C) confirmed that after the printing process, spheroids
were still able to grow out, and that is, dependent on their initial
position, either on the outer surface of the printed construct or
deeper into the hydrogel (Figure 10D). When deposited in close
proximity to each other, spheroids were able to fuse in the printed
construct [indicated by black arrows, Figure 9C(a,c)]. Culturing
of the bioprinted scaffolds for 14 days, showed that scaffolds
retained their 3D structure and that spheroids remained at their
initial 3D spatial position (Figure 10A). The printing process
did not affect spheroid viability as observed by live/dead staining
(Figures 10B–D). 14 days post printing, spheroids and sprouts
of nearly surfacing, partially protruding and fully encapsulated
spheroids were still viable (Figures 10B–D). However, complete
fusion of cartilage microtissues was not obtained yet.
Histological evaluation and macroscopic pictures confirmed
the 3D printed pattern composed of struts and pores (Figure 11,
first row). Microscopical histological evaluation showed that
post printing spheroids displayed good morphology with intact
nuclei throughout the entire spheroids. More importantly,
spheroid ECM was not altered or did not deteriorate after
enduring the printing process. 7 days post printing, spheroids
displayed high GAG and collagen type II content, and low to
no collagen type I presence, which is in line with the results
of the encapsulation experiments, no significant differences
were observed for the ECM components in comparison with
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FIGURE 9 | 3D bioprinting of 14-day-mature cartilage microtissues in gelMA/Li-TPO-L (A) Representation of (a) the CAD model and (b–f) macroscopic to
microscopic representation of the printed scaffolds. Scale bars 500 µm (b), 800 µm (c), 500 µm (d,e), 200 µm (f). (B) Scanning Electron Microscopy (SEM)
evaluation of bioprinted scaffolds. Black arrow indicates cellular sprouts of adjacent spheroids making contact, initiating fusion (b) and white arrows (b,c) indicate
cellular outgrowth. Scale bar 200 µm (a), 100 µm (b,d), 50 µm (c,e). (C) Fusion and cellular outgrowth of spheroids 4 days (a) and 14 days (b,c) post printing
within the gelMA. Black arrows indicate tissue fusion. Scale bar 200 µm.
the encapsulated spheroids (Figures 11A,B). Moreover, GAG
and collagen type II content increased over time in culture
from 43.40 ± 2.75% to 52.82 ± 5.63% and 36.79 ± 6.75%
to 52.45 ± 4.15%, respectively, 7 and 14 days post printing
(Figure 11B). Bioprinting of spheroids clearly outperformed
the bioprinting with single cells (Figure 12). Constructs with
single cells showed poor viability 7 days post printing and
no chondrogenic differentiation was observed after 14 days.
Spheroids seem to withstand the printing process better, probably
because of their robust ECM.
DISCUSSION
Cell-based regenerative therapies for cartilage repair and
regeneration are trending, with (M)ACI as a well-known
example. However, this procedure often results in the creation
of reparative tissue, with inferior quality and lacking durability
when compared to the native tissue. This can be attributed
to chondrocytes having the tendency to dedifferentiate during
expansion in 2D culture (Dewan et al., 2014; Deng et al., 2016;
Onofrillo et al., 2018; De Moor et al., 2019). Moreover, the
application of individual cells fails to mimic the complex cell-
cell and cell-matrix interactions present within a 3D tissue,
which hinders the accurate imitation of the early events in tissue
development (Gionet-Gonzales and Leach, 2018).
In the search for an alternative to freely inject or transplant
cells into the defect site, 3D bioprinting holds a great promise
to fabricate a tissue construct mimicking the native tissue by
the directed assembly of microscale building blocks into a
larger tissue construct. We explored a hybrid strategy combining
cellular microtissues, biomaterials and 3D printing technology.
For the first time, small spheroids of BM-MSC were generated
using a cost-effective system and the potential of a low-cost
modified version of the natural polymer gelatin (gelMA) was
tested to serve as an instructive ink for cartilage microtissues
to create a macroscale tissue. This work aimed to elucidate
if BM-MSC spheroids are able to differentiate into cartilage
microtissues and how they respond to encapsulation in a gelMA
hydrogel environment. The promise of this approach is that
in future studies cartilage microtissues of different maturation
stages mimicking endochondral ossification could be printed
in a stratified pattern resembling osteochondral interfaces. This
stratified approach cannot be obtained by current clinical therapy
with injecting of cells or spheroids (chondrospheres).
Prior to encapsulation of spheroids with gelMA, different
culture times were evaluated to select the maturation stage of
the cartilage microtissue (optimal spheroid diameter and ECM
content). Self-assembled 3D cartilage microtissues from human
BM-MSC were successfully generated using a non-adhesive
agarose microwell system. This high-throughput technique
allowed the controlled formation of spheroids with a mean
diameter of 116.73 µm after 14 days of culture, which is
an optimal geometry for deposition by the print needle. 3D
microtissues can be created in several other ways, using pellet
culture, spinner flask culture, hanging drop method, etc., the
main disadvantages of these techniques are the heterogeneity
of the spheroids (intervariability in dimensions is reflected
in suboptimal chondrogenic differentiation), the quantity of
the produced spheroids and the intensive manual labor for
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FIGURE 10 | Viability of cartilage microtissues post 3D bioprinting. The viability of spheroids bioprinted at maturation stage of 14 days was assessed by live/dead
staining with ca-AM/PI after 1, 7, and 14 days post printing. (A) Brightfield images, (B) fluorescent images of ca-AM/PI staining and (C) merged brightfield and
ca-AM/PI images. Scale bars 500 µm (overview) and 200 µm (insert). (D) Cell outgrowth within printed constructs 14 days post printing. Cells spreading out from a
surfacing spheroid (lower spheroid) toward a deeper situated spheroid (upper spheroid). Scale bar 500 µm.
the exchange of culture medium and spheroid harvesting
(Achilli et al., 2012).
In this study, the spheroids were homogeneous in shape and
size, crucial for efficient deposition by 3D bioprinting. In addition
to homogeneity and stability in diameter and circularity along
the culture period, spheroids showed a high viability during
chondrogenesis, which started from 14 days in culture, indicated
by the manifestation of cartilage ECM components such as GAG
and collagen II. Histological analysis also showed that GAG
and collagen II increased over the 42 days of spheroid culture
time. Chondrogenesis was induced by a low oxygen culture
environment, mimicking the physiological concentration and
the application of a serum-free chondrogenic culture medium
containing TGF-β1. It has been described that TGF-βs contribute
in the regulation of chondrogenic differentiation from the early to
terminal stages, including condensation, proliferation, terminal
differentiation and maintenance of articular chondrocytes. More
specifically, the TGF-β1 signaling pathway induces mesenchymal
condensation via up-regulation of N-cadherin and fibronectin
and TGF-β1 treatment initiates chondrogenesis of mesenchymal
progenitor cells (Wang et al., 2014). In this regard, it is
important that spheroid cultures have a low variability in
spheroid dimensions allowing to homogeneously differentiate
into the cartilage phenotype and leading to thousands of cartilage
microtissues at the same maturation stage.
Hydrogels have been widely used as 3D matrices for cell
application. They are used as a medium for the retention of
cells after injection in the cartilage defect site or as a carrier
for cells or spheroids during bio-ink based extrusion printing to
ensure shape fidelity of the construct (Moldovan et al., 2018; Li
et al., 2019). Common biomaterials used in cartilage engineering
are collagen, alginate, hyaluronic acid, etc., because of their
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FIGURE 11 | Evaluation of cartilaginous phenotype of microtissues post printing. (A) HE staining was performed to assess overall morphology, Alcian Blue staining
showed the presence of glycosaminoglycans (GAG). Collagen was visualized by Picrosirius Red (PSR) staining and IHC stainings for collagen type I and type II were
performed. Scale bar 20 µm. (B) Graphs represent the quantification of GAG, collagen I and collagen II positive stained areas within bioprinted spheroids as
compared to encapsulated spheroids in gelMA/Li-TPO-L and non-encapsulated spheroids from corresponding culture timepoints. All data are presented as
mean ± 95% CI. For non-encapsulated spheroids, significant differences (p < 0.05) between culture timepoints were marked a compared to day 14, b to day 21,
and c to day 28 spheroids. For encapsulated spheroids significant differences (p < 0.05) between culture timepoints were marked d compared to 7 days post
encapsulation and e to 14 days post encapsulation. For bioprinted spheroids significant differences (p < 0.05) between culture timepoints were marked f compared
to 7 days post printing and g to 14 days post printing. For both encapsulated (in gray) and bioprinted spheroids (in black) significant differences compared to the
non-encapsulated spheroid controls were marked * (n = 6, One-way ANOVA followed by a Tukey’s post hoc test).
resemblance with the native tissue ECM (Li et al., 2019). In this
work gelMA was chosen because it has shown to be a permissive
environment for neo-cartilage formation when cell suspensions
of chondrocytes or MSC are encapsulated (Levato et al., 2017;
Rothrauff et al., 2017). After encapsulation, cartilage microtissues
proved to retain their geometry and although the crosslinking
process involving UV-light could be detrimental for cell viability,
it was preserved in the hydrogel. However, a shift in proliferative
capacity was observed after embedding in gelMA, limited Ki67
positive cells were found in comparison to non-encapsulated
spheroids. Although this lack of Ki67 staining, light microscopic
evaluation showed the cellular outgrowth. Similar results were
reported when spheroids of human adipose-derived MSC were
encapsulated in 5, 7.5, and 10 w/v% gelMA hydrogels: sprouting
was observed and was more pronounced in the softest gels
(Žigon-Branc et al., 2019). In this study, outgrowth of cells was
especially seen in the softer gelMA hydrogels crosslinked with Li-
TPO-L as a PI. Interestingly, these hydrogels with a significantly
lower Young’s modulus did display a higher gel fraction than
hydrogels crosslinked with Irgacure 2959. The latter is expected
because a LED with higher intensity was used to crosslink the
Li-TPO-L gels and Li-TPO-L has an absorption maximum at
approximately 375 nm. Therefore, at the wavelength of 365 nm,
it provides better reactivity compared to Irgacure 2959, whose
absorption already tails out in this spectral range and Li-TPO-
L also exhibits a higher efficiency and yield of radical formation
(Markovic et al., 2015). It is hypothesized that crosslinking with
Li-TPO-L probably results in a more homogenously distributed
network throughout the entire hydrogel, as compared to Irgacure
2959 which possibly results in a more heterogeneously distributed
crosslinked network with initial crosslinking at the surface and
less transmission of the UV-light deeper in the gel, explaining
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FIGURE 12 | Evaluation of bioprinted single cells. (A) Morphology and viability of bioprinted single cells 7 days post printing. Scale bars 200 µm. (B) HE staining was
performed to assess overall morphology, Alcian Blue staining showed the presence of glycosaminoglycans (GAG) and IHC stainings for collagen type I and type II
were performed. Scale bar 20 µm.
the higher mechanical strength but lower gel fraction. Moreover,
different crosslinking times and light sources with different
intensities were used to crosslink the Irgacure 2959 and Li-
TPO-L gels, respectively, explaining the differences in mechanical
properties and gel fraction.
Regardless of the hydrogel stiffness, the encapsulated
chondrogenic induced spheroids presented a GAG- and collagen
type II-rich ECM, increasing with time in culture in the hydrogel.
It was already described by Salamon et al. (2014) that gelMA
had a pro-chondrogenic impact on MSC. When adipose-derived
MSC were seeded on top of gelMA films, an upregulation of
Sox9, Sox5, and Col2a1 gene expression was described (Salamon
et al., 2014). Moreover, seeding adipose-derived MSC on gelMA
resulted in a stronger accumulation of GAG compared to
controls (Salamon et al., 2014). We also observed that gelMA
encapsulation had a cumulative effect on GAG production
within spheroids and Roosens et al. (2019) reported the same
trend when spheroids consisting of valvular interstitial cells were
encapsulated. The constructs with lower stiffness resulted in
a downregulation of collagen I and an increase in collagen II
production. Žigon-Branc et al. (2019) also demonstrated that
the extent of chondrogenic differentiation of MSC spheroids was
more pronounced in softer hydrogels.
The bioprinting processability of spheroid-laden gelMA/Li-
TPO-L bio-ink was improved after optimization of the printhead
heater and environmental temperature. Hence, gelMA scaffolds
with encapsulated cartilage microtissues demonstrated good
shape-fidelity. Moreover, the printed scaffolds were stable for
the entire culture period and spheroid viability and phenotype
remained after enduring the printing process. For the creation
of large scale constructs with relevant mechanical strength,
the hydrogel can be reinforced with a synthetic polymer such
as polycaprolactone (PCL), a popular polymer due to its
superior rheological and viscoelastic properties (Woodruff and
Hutmacher, 2010). Daly et al. (2016) co-deposited hydrogel bio-
inks with PCL filaments and PCL-reinforced hydrogel scaffolds
had compressive moduli (2 MPa) similar to that of native
articular cartilage. Co-depositioning with PCL fibers can lead
to stress shielding if the young’s modulus of the implant is
higher than the modulus of the surrounding tissue which will
lead to the PCL fibers carrying most of the externally applied
forces. It is important to keep this strain mismatch between
implant and surrounding tissue limited, preventing poor implant
performance and surrounding tissue damage (Wintermantel
et al., 2001; Farag, 2017).
Recently, a material-free assembly method was used to
create a cartilage construct starting from spheroids (Grogan
et al., 2019). The Kenzan bioprinting method does not use
any material support structure, but relies on natural cell-to-
cell contact behavior and spheroid fusion after fixation upon
microneedles that provide temporary support (Moldovan et al.,
2017). Spheroids used for this method are characterized by
a large diameter (>500 µm) (Grogan et al., 2019). However,
creating viable tissues with large diameter is challenging
due to the diffusion limit (100–200 µm) (Radisic et al.,
2006; Liu et al., 2015). Especially centrally located cells of
an engineered construct, lack sufficient supply of nutrients
and oxygen, and are unable to dispose metabolic products
(e.g., CO2), causing poor viability (Alvarez-Pérez et al.,
2005; Gaskell et al., 2016). For this reason, we opted to
start from small diameter spheroids. Their ability to fuse
is essential in this synergistic hybrid tissue engineering
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approach, as tissue fusion is the fundamental biological
process to build larger structures. When two spheroids were
placed together, creating a doublet, cartilage microtissue
fusion was completed after 72 h of culture as indicated
by reaching a plateau of the intersphere angle. During the
first 24 h of fusion, doublet length and width decreased,
suggesting the compaction process. Doublet length further
decreased but doublet width started to increase, approaching
the measurements of the doublet length indicating that
doublets started to compact and dynamically reorient to a
circular shape. The fused doublet displayed cartilage specific
molecules, GAG and collagen II, GAG were dispersed throughout
the fused doublet, while collagen II was mainly present
in the newly synthesized matrix surrounding the original
individual spheroids. Doublet fusion of primary chondrocyte
spheroids was already described by Parfenov et al. (2018) and
Susienka et al. (2016) Both studies showed that sheep and
human primary chondrocyte spheroids/doublets, respectively,
were able to fuse (Susienka et al., 2016; Parfenov et al.,
2018). Our study investigated, for the first time, fusion and
morphological changes during chondrogenic induced BM-MSC
doublet formation.
Doublet fusion could be transferred to fusion of multiple
spheroids in an agarose coated well. A compact macrotissue
was created after 96 h which showed increased circularity over
time in culture. Notably, there was no presence of collagen
type II in the center of the fused construct, this can be
explained by the use of immature day 7 spheroids, where
there is no manifestation of ECM, and the limited diffusion
of nutrients into the core of the macrotissue. Spheroid fusion
was still observed when spheroids were encapsulated in gelMA
hydrogels in close proximity to each other, demonstrating
the tissue-fusion-permissive potential of the hydrogel. This
was confirmed after completing the printing process where
spheroids within the scaffold structure were still able to fuse.
However, we want to highlight the time discrepancy between
spheroid fusion in the absence versus in the presence of a
hydrogel. Complete fusion of spheroids is obtained after 72 h
in absence of a hydrogel, as indicated by an intersphere angle
of ±179◦. When spheroids are encapsulated or bioprinted in
gelMA, fusion is highly dependent on a close deposition of
neighboring spheroids. Encapsulated spheroids in gelMA did
not completely fuse during the 14-day time frame of the
experiment, shown by an intersphere angle of 127◦. This was
in part due to the difference in age of the used spheroids,
the spheroids used in the non-encapsulated fusion experiments
were 7-day-old spheroids, while 14-day-matured spheroids were
encapsulated or bioprinted. It has been described that fusion
of older spheroids results in incomplete fusion showing the
individual margins of the spheroids (De Moor et al., 2018).
Nevertheless, while hydrogel degradation will occur in vivo,
spheroids will have enhanced probability to fuse. This underlines
the importance of research dedicated to find hydrogels or
biomaterials with altered characteristics having the capability to
enhance the functionality of bioprinted tissues. This field of smart
biomaterials research will definitely have a positive impact on the
biofabricated tissues.
Traditional ACI procedures using a cell suspension of
chondrocytes, or MACI procedures using cells in combination
with a scaffold, are indicated for large femoral defects of
2–10 cm2 and 2 million autologous cells/cm2 are applied
(Foldager et al., 2012; Becher et al., 2017; Krill et al., 2018). Only
12–26 weeks after implantation of the single cell suspension,
cartilage matrix develops (Becher et al., 2017; Krill et al.,
2018). The major advantage of using spheroids instead of
single cells is that, because of the high cell-cell contacts and
cell density in 3D preculture, they already have developed a
tissue specific ECM, before they are used for implantation
(Bartz et al., 2016; De Moor et al., 2019). We believe the
use of spheroids will lead to a less fibrous tissue than
traditional ACI because they already possess a GAG- and
collagen II-rich ECM. Moreover, spheroids combined with
gelMA also displayed a significantly less fibrous and a more
hyaline cartilage-like phenotype. Interestingly, bioprinting of
spheroids seems to be more successful than bioprinting of
single cells since constructs containing single cells showed poor
viability, and more importantly no chondrogenic differentiation
(Figure 12). When using spheroids as building blocks, the
concentration of spheroids in the bio-ink needs to be optimized.
One bioprinted construct of four layers was printed, with
dimensions of 1.3 cm × 1.3 cm and thus covering an area
of 1.69 cm2, using ±167 µl of bio-ink. The concentration
of spheroids in the bio-ink was 12680 spheroids/ml, thus 1
construct contained ±2113 spheroids/1.69 cm2 which equals
1250 spheroids/cm2. We suggest to increase the concentration
in accordance with the clinically applied cell concentration
in traditional ACI (2 million cells/cm2), this corresponds
with 4 seeded microwells and thus 6340 spheroids/cm2.
To achieve a similar concentration as in traditional ACI,
the spheroid concentration in the bio-ink needs to be a
fivefold higher (±63400 spheroids/ml, corresponding with
40 microwells). Enhanced fusion of spheroids will be the
result of the increased spheroid concentration. In vivo, the
gelMA scaffold will be prone to degradation, leading to softer
hydrogels with impact on nutrient diffusion, spheroid fusion and
cellular outgrowth.
Our study shows that 3D cartilage microtissues can be
bioprinted while maintaining cell viability, 3D architecture,
chondrogenic phenotype and their fusion capacity. The
versatile fusion capacity of microtissues is interesting
for future in vivo implantation as this shows the broad
spectrum of application possibilities. Spheroids can be used
as such, or in combination with gelMA as an injectable.
Highly interesting is that a patient-specific implantable
construct could be manufactured by 3D bioprinting of
chondrogenic induced spheroids at various endochondral
developmental stages giving the promise of treating stratified
osteochondral defects.
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